✦ LIBER ✦

Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes

✍ Scribed by Castelli, Roberto; Cassin, Ramona; Cannavò, Antonino; Cugno, Massimo

Book ID: 122089380
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 314 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.09.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The immunomodulatory agents lenalidomide

The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline

✍ Leitch, Heather A.; Buckstein, Rena; Shamy, April; Storring, John M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 333 KB

5-Azacytidine for the treatment of myelo

5-Azacytidine for the treatment of myelodysplastic syndromes

✍ Krawczyk, Janusz; Keane, Niamh; Freeman, Ciara Louise; Swords, Ronan; O'Dwyer, M 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 579 KB

New treatment option for the antiphospho

New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs

✍ R.L. Brey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

New agents in the treatment of childhood

New agents in the treatment of childhood leukemias and myelodysplastic syndromes

✍ Seth J. Corey 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 281 KB

Azacytidine for the treatment of myelody

Azacytidine for the treatment of myelodysplastic syndromes in the elderly

✍ Maria Diez Campelo; Regina Garcia Delgado; Ana Cristina Godoy Molias; Jesus Feli 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 464 KB

Is Traditional Low-Dose Chemotherapy (Cy

Is Traditional Low-Dose Chemotherapy (Cytarabine/Melphalan) Still an Option for the Treatment of Myelodysplastic Syndromes?

✍ Whittle, Annika M.; Bowen, David T. 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB